BioNTech SE (BNTX)
NASDAQ: BNTX · Real-Time Price · USD
112.41
+8.91 (8.61%)
Sep 5, 2025, 3:32 PM - Market open
BioNTech SE Market Cap
BioNTech SE has a market cap or net worth of $27.02 billion as of September 5, 2025. Its market cap has increased by 26.38% in one year.
Market Cap
27.02B
Enterprise Value
10.99B
1-Year Change
26.38%
Ranking
Category
Stock Price
$112.41
Market Cap Chart
Since October 10, 2019, BioNTech SE's market cap has increased from $2.99B to $27.02B, an increase of 802.28%. That is a compound annual growth rate of 45.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2025 | 24.88B | -8.92% |
| Dec 31, 2024 | 27.32B | 8.89% |
| Dec 29, 2023 | 25.09B | -31.28% |
| Dec 30, 2022 | 36.51B | -41.37% |
| Dec 31, 2021 | 62.26B | 217.21% |
| Dec 31, 2020 | 19.63B | 156.06% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 10, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 666.94B |
| Johnson & Johnson | 430.51B |
| AbbVie | 376.28B |
| UnitedHealth Group | 281.10B |
| AstraZeneca | 253.90B |
| Novo Nordisk | 249.80B |
| Novartis AG | 249.52B |
| Abbott Laboratories | 231.15B |